Single-nucleotide polymorphisms of VEGF gene are associated with risk of congenital valvuloseptal heart defects
- PMID: 16569553
- DOI: 10.1016/j.ahj.2005.10.012
Single-nucleotide polymorphisms of VEGF gene are associated with risk of congenital valvuloseptal heart defects
Abstract
Background: Disturbed vascular endothelial growth factor (VEGF) production during early heart morphogenesis causes endocardial cushion malformation, which results in congenital heart disease (CHD). We tested whether functional VEGF -460T/C and +405G/C polymorphisms that have an impact on VEGF levels were associated with CHD.
Methods: Dried blood samples were collected from 102 CHD children and 112 healthy control neonates. Genotyping was done with polymerase chain reaction-restriction fragment length polymorphism (VEGF +405G/C) and real-time polymerase chain reaction methods (VEGF -460T/C).
Results: VEGF -460C allele frequency was similar in control and CHD subjects. VEGF +405C allele was less prevalent in controls than in CHD subjects (0.21 vs 0.42, P < .001). Having VEGF +405C presented increased risk for CHD (odds ratio [OR] 1.72, 95% CI 1.32-2.26). VEGF -460CT/+405CC allele associations did not occur in controls but in CHD patients (0% vs 13%, OR 2.26, 95% CI 1.93-2.64), whereas -460CT/+405GG allele association was more prevalent in controls (32% vs 16%, OR 0.58, 95% CI 0.37-0.89).
Conclusions: VEGF gene and allele associations may be associated with increased risk of CHD.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
